Heartbeam, Inc. - Common Stock (NQ:BEAT)

0.6718 +0.2372 (+54.58%)

Delayed Quote Updated: 10:08 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Heartbeam, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Global Supplier of Non-Invasive Cardiac Monitoring Systems Expanding Via New Partnerships & OTCQB Uplisting Efforts: CB Scientific Stock Symbol: CBSC

December 01, 2021

Via Get News

Topics Supply Chain

HeartBeam Announces Closing of Initial Public Offering

November 17, 2021

From HeartBeam, Inc.

Via Business Wire

EXCHANGE LISTING, LLC ADVISES HEARTBEAM INC. AND SECURES NASDAQ LISTING

November 15, 2021

MedTech Innovator Advances Portable, Medical Grade Heart Attack Detention

Via News Direct

Topics Initial Public Offering

CYTO Stock: The Nasal Spray News Blowing Altamira Therapeutics Sky-High Today ↗

November 12, 2021

Altamira Therapeutics (CYTO) stock is rocketing higher on Friday following the release of positive results from a nasal spray test.

Via InvestorPlace

SNDL Stock: The Good News That Has Cannabis Play Sundial Growers Heading Higher Today ↗

November 12, 2021

Sundial Growers (SNDL) stock is on the rise Friday following a couple of bits of positive news from the marijuana company.

Via InvestorPlace

Topics Cannabis

HeartBeam IPO: Why BEAT Stock Has Investors’ Hearts Racing Friday ↗

November 12, 2021

A heart health innovator went public yesterday. Here's why you shouldn't be worried by the turbulence of the HeartBeam IPO.

Via InvestorPlace

Topics Initial Public Offering

HeartBeam Announces Pricing of $16.5 Million Initial Public Offering

November 10, 2021

From HeartBeam, Inc.

Via Business Wire

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.